Key result
Wuqinxi exercise significantly improved systolic blood pressure (SMD 0.62; 95% CI 0.38-0.85; p<0.001) and other cardiovascular risk factors associated with metabolic syndrome.
Why the study?
Metabolic syndrome is increasingly prevalent, making effective methods to combat or prevent it a critical public health priority.
Does Wuqinxi exercise improve risk factors associated with metabolic syndrome?
Meta-Analysis
Does Wuqinxi exercise improve risk factors associated with metabolic syndrome?
Standardized Mean Difference: 0.62 (95% CI 0.38–0.85)
p-value: p=< 0.001
Wuqinxi exercise significantly improves blood pressure and lipid profiles, suggesting it is an effective alternative exercise for managing metabolic syndrome risk factors.
Wuqinxi supports metabolic syndrome management as an alternative exercise; extends evidence for traditional Chinese exercises in cardiometabolic risk reduction.
Background: The improvement of living standards has led to increases in the prevalence of hypokinetic diseases. In particular, multifactorial complex diseases, such as metabolic syndrome, are becoming more prevalent. Currently, developing effective methods to combat or prevent metabolic syndrome is of critical public health importance. Thus, we conducted a systematic review to evaluate the existing literature regarding the effects of Wuqinxi exercise on reducing risk factors related to metabolic syndrome. Methods: Both English- and Chinese-language databases were searched for randomized controlled trials investigating the effects of Wuqinxi on these outcomes. Meanwhile, we extracted usable data for computing pooled effect size estimates, along with the random-effects model. Results: The synthesized results showed positive effects of Wuqinxi exercise on systolic blood pressure (SBP, SMD = 0.62, 95% CI 0.38 to 0.85, p < 0.001, I2 = 24.06%), diastolic blood pressure (DBP, SMD = 0.62, 95% CI 0.22 to 1.00, p < 0.001, I2 = 61.28%), total plasma cholesterol (TC, SMD = 0.88, 95% CI 0.41 to 1.36, p < 0.001, I2 = 78.71%), triglyceride (TG, SMD = 0.87, 95% CI 0.49 to 1.24, p < 0.001, I2 = 67.22%), low-density lipoprotein cholesterol (LDL-C, SMD = 1.24, 95% CI 0.76 to 1.72, p < 0.001, I2 = 78.27%), and high-density lipoprotein cholesterol (HDL, SMD = 0.95, 95% CI 0.43 to 1.46, p < 0.001, I2 = 82.27%). In addition, regression results showed that longer-duration Wuqinxi intervention significantly improved DBP (β = 0.00016, Q = 5.72, df = 1, p = 0.02), TC (β = −0.00010, Q = 9.03, df = 1, p = 0.01), TG (β = 0.00012, Q = 6.23, df = 1, p = 0.01), and LDL (β = 0.00011, Q = 5.52, df = 1, p = 0.02). Conclusions: Wuqinxi may be an effective intervention to alleviate the cardiovascular disease risk factors of metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2019) conducted a meta-analysis in Metabolic syndrome. Wuqinxi Qigong was evaluated on Systolic blood pressure (SBP) (SMD 0.62, 95% CI 0.38 to 0.85, p=< 0.001). Wuqinxi exercise significantly improved systolic blood pressure (SMD 0.62; 95% CI 0.38-0.85; p<0.001) and other cardiovascular risk factors associated with metabolic syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: